Target intelligence / Profile preview

Salmonid alphavirus subtype 3 (SAV3)

Target
SAV3
Molecular classification
Virus, Alphavirus, Togaviridae
01

Overview

Salmonid alphavirus subtype 3 is a single-stranded, positive-sense RNA virus belonging to the family Togaviridae and genus Alphavirus[3][7]. It is one of six genetic subtypes of salmonid alphavirus and is the causative agent of pancreas disease (PD) in farmed Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss), predominantly in Norway[1][2][3][4][5][7]. The viral genome encodes eight proteins, including structural glycoproteins (E1, E2, E3, 6K) and nonstructural proteins (nsP1–4)[3][7]. Infection with SAV3 leads to pancreas disease, which can cause significant morbidity and mortality in aquaculture, resulting in major economic losses[1][2][4][7]. Vaccines based on inactivated virus are commercially available and are the primary method of disease control in aquaculture[3]. SAV3 is classified as a viral pathogen, not a classical therapeutic target (such as receptor, enzyme, etc.), and should not be treated as a molecular target for pharmacological modulation in the classical sense, but as a pathogen for prophylactic vaccine development[3][7].

Other names
Salmon pancreas disease virus subtype 3Pancreas disease virus subtype 3SAV 3Salmonid alphavirus 3
02

Mechanism of action

Vaccines induce protective immune response against viral infection

03

Biological functions

Infection of fish (notable in Atlantic salmon and rainbow trout)Induction of immune response in fish
04

Disease associations

InfectionPancreas disease in fish
05

Safety considerations

Virus transmission in aquaculturehigh morbidity and mortality in affected fish populationspotential for economic loss
06

Interacting drugs

Commercial vaccines (e.g., AquaVac PD3, Norvax Compact PD)
07

Biomarkers

Viral RNA (detected by RT-qPCR for diagnosis)IgM antibody responses in fish

Beyond the preview

Go deeper on Salmonid alphavirus subtype 3 (SAV3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonid alphavirus subtype 3 (SAV3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call